18-01-2022

A Smartfish drink fortified with B vitamin is an effective intervention strategy for improving B vitamin status among older adults

DUBLIN, ULSTER, OSLO AND LUND, JANUARY 18, 2021

Heffernan and colleagues have published the results from their OptiAge food intervention study demonstrating improvements in all B vitamin biomarkers among participants who received the B vitamin fortified Smartfish drink compared to the participants who received the placebo. The researchers concluded that the B vitamin fortified Smartfish drink is a useful intervention strategy for improving B vitamin status in older adults.

A high proportion of older adults are reported to have sub-optimal B vitamin status resulting in the necessity of developing new nutritional strategies, including novel foods, targeted towards the elderly. This multicenter double-blind randomized controlled trial was conducted at the University College Dublin and Ulster University with the aim to develop and investigate the effectiveness of a B vitamin fortified Smartfish drink in improving B vitamin biomarkers in older adults.

The fortified drinks were manufactured to contain 200 µg folic acid, 10 µg vitamin B12, 10 mg vitamin B6 and 5 mg riboflavin in the active version, while the placebo was an identical, isocaloric formulation which did not contain B vitamins. Both the intervention and the placebo drinks contained 10 µg vitamin D. Participants were randomly assigned to consume either the B vitamin fortified Smartfish drink or the placebo for 16 weeks.  

A total of 70 participants (>50 years old) completed the study in which 37 received the Smartfish drink and 33 received the placebo. Compliance was high among the participants, with >90% compliance in 59 participants, 80-90% compliance in 7 participants, and <80% compliance in only one participant. Furthermore, significant improvements in all B vitamin biomarkers including folate, vitamin B12, vitamin B6 and riboflavin were found in the active group compared to placebo group. Additionally, maintenance of vitamin D status was achieved for participants in both groups during the winter months with the daily consumption of 10 µg of vitamin D present in the drinks. The high compliance, the maintenance of vitamin D status, and the increase in B vitamin biomarkers demonstrate that a B vitamin fortified Smartfish drink is well accepted by older adults and is effective in maintaining vitamin D status and optimizing vitamin B status in the target group.

Fortified drinks such as this B vitamin fortified Smartfish drink enable the administration of nutrition including vitamins in a highly accepted format resulting in the high compliance depicted in this study. The high compliance and the observed increase in B-vitamin biomarkers are highly encouraging and serve as a strong basis for further research in this area, says Geir Harstad, CEO of Smartfish.

The study Effectiveness of a fortified drink in improving B vitamin biomarkers in older adults: a controlled intervention trial (nih.gov) was recently published in Nutrition & Metabolism.

 

About Smartfish AS 

Smartfish AS is active within research, development, production and marketing of advanced clinically documented nutritional drinks in the field of medical nutrition and sports nutrition. All Smartfish products are produced on its proprietary juice-based emulsion technology platform with the marine DHA and EPA fatty acids as important ingredients. The products are mainly sold through recognized international partners and distributors. Smartfish has a number of ongoing clinical development projects and studies in close collaboration with researchers and institutions both in Norway and internationally.  

The company was founded in 2001 and is located in Oslo, Norway and Lund, Sweden. Smartfish’s main shareholders are Investinor (Norway) and Industrifonden (Sweden). Learn more on https://www.smartfishnutrition.com

 

For more information, please contact: 

Johan Olsson, Head of R&D of Smartfish, Phone: +46 732 032 804  

Geir Harstad, CEO of Smartfish, Phone: + 46 763151160 

  

News

27-04-2022

Smartfish is hiring a Product Development and Quality Manager

01-02-2022

Johan Olsson appointed acting CEO

20-12-2021

A new medical nutrition development project targeting patients with cancer ca ...

01-09-2021

Johan Wahlqvist appointed Commercial Director

30-08-2021

Press release: Omega-3 fatty acids in the Smartfish emulsion is safe and tole ...

19-05-2021

Johan Olsson has been promoted to Head of R&D and Supply Chain at Smartfish

04-03-2021

Smartfish´s medical nutrition product Remune® to be used in international res ...

06-01-2021

A new study sheds light on the prevalence and impact of vitamin D deficiency ...

18-12-2020

COVID-19 has highlighted the importance of nutrition for a well-functioning i ...

12-11-2020

Researchers investigate whether fish oil including omega-3 and vitamin D can ...